Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$47,736,000
+$19,756,000 QoQ
Shares Held
1,350,000
+35.0% QoQ
Ownership
0.810%
of shares outstanding
% of Portfolio
2.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$748,980
PutShares
27,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Affinity Asset Advisors, LLC holds $89,904,000 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (53.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
1,350,000 | $47,736,000 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,000 | $42,168,000 |
All Filings in ALKS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,736,000 | 1,350,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,980,000 | 1,000,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $37,500,000 | 1,250,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $28,610,000 | 1,000,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $33,020,000 | 1,000,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $31,636,000 | 1,100,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,990,000 | 1,000,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,665,000 | 650,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,030,250 | 75,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,886,092 | 356,384 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $748,980 | 27,000 | Put | Sole | 2024-02-13 | |
| 2023-09-30 | $2,801,000 | 100,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $5,602,000 | 200,000 | Call | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||